These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1638554)
1. An extract of seeds from Aeginetia indica L., a parasitic plant, induces potent antigen-specific antitumor immunity in Meth A-bearing BALB/c mice. Chai JG; Bando T; Kobashi S; Oka M; Nagasawa H; Nakai S; Maeda K; Himeno K; Sato M; Ohkubo S Cancer Immunol Immunother; 1992; 35(3):181-5. PubMed ID: 1638554 [TBL] [Abstract][Full Text] [Related]
2. Th1-cytokine induction and anti-tumor effect of 55 kDa protein isolated from Aeginetia indica L., a parasitic plant. Ohe G; Okamoto M; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Uyama K; Bando T; Yoshida H; Sakai T; Himeno K; Sato M; Ohkubo S Cancer Immunol Immunother; 2001 Jul; 50(5):251-9. PubMed ID: 11499808 [TBL] [Abstract][Full Text] [Related]
3. Dissociation between the mitogenic effect and antitumor activity of seed extract from Aeginetia indica L. Chai JG; Okamoto M; Bando T; Nagasawa H; Hisaeda H; Sakai T; Himeno K; Sato M; Ohkubo S Immunopharmacology; 1995 Sep; 30(3):209-15. PubMed ID: 8557520 [TBL] [Abstract][Full Text] [Related]
4. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors. Fuyama S; Komatsu H; Arai S Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379 [TBL] [Abstract][Full Text] [Related]
5. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). Harada M; Seta K; Ito O; Tamada K; Li T; Terao H; Takenoyama M; Kimura G; Nomoto K Immunopharmacol Immunotoxicol; 1995 Nov; 17(4):687-703. PubMed ID: 8537606 [TBL] [Abstract][Full Text] [Related]
6. Seed extract of Aeginetia indica L induces cytokine production and lymphocyte proliferation in vitro. Chai JG; Bando T; Nagasawa H; Himeno K; Sato M; Ohkubo S Immunopharmacology; 1994; 27(1):13-21. PubMed ID: 8206751 [TBL] [Abstract][Full Text] [Related]
7. Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors. Fujioka T; Ishikura K; Tanji S; Okamoto T; Koike H; Aoki H; Ohhori T; Kubo T Int J Immunopharmacol; 1990; 12(4):419-26. PubMed ID: 2391188 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of astaxanthin and its mode of action. Jyonouchi H; Sun S; Iijima K; Gross MD Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217 [TBL] [Abstract][Full Text] [Related]
9. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma. Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse. Ebina T; Kohya H; Ishikawa K Jpn J Cancer Res; 1989 Feb; 80(2):158-66. PubMed ID: 2498250 [TBL] [Abstract][Full Text] [Related]
11. Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene. Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T J Natl Cancer Inst; 1987 Apr; 78(4):679-81. PubMed ID: 3470543 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma. Gomi K; Morimoto M; Nomoto K Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702 [TBL] [Abstract][Full Text] [Related]
13. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Micallef MJ; Yoshida K; Kawai S; Hanaya T; Kohno K; Arai S; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Kurimoto M Cancer Immunol Immunother; 1997 Jan; 43(6):361-7. PubMed ID: 9067408 [TBL] [Abstract][Full Text] [Related]
14. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12. Ogawa M; Tsutsui T; Zou JP; Mu J; Wijesuriya R; Yu WG; Herrmann S; Kubo T; Fujiwara H; Hamaoka T Cancer Res; 1997 Jun; 57(11):2216-22. PubMed ID: 9187124 [TBL] [Abstract][Full Text] [Related]
15. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells]. Tsujino M Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404 [TBL] [Abstract][Full Text] [Related]
16. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850 [TBL] [Abstract][Full Text] [Related]
17. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system]. Ebina T; Shishido K; Murata K Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138 [TBL] [Abstract][Full Text] [Related]
18. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice. Kato I; Yokokura T; Mutai M Cancer Immunol Immunother; 1988; 26(3):215-21. PubMed ID: 3133111 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of methanol extract from roots of Agrimonia pilosa Ledeb. Koshiura R; Miyamoto K; Ikeya Y; Taguchi H Jpn J Pharmacol; 1985 May; 38(1):9-16. PubMed ID: 4040585 [TBL] [Abstract][Full Text] [Related]
20. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer. Masuda E; Maeda H Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]